People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Telecommunications, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CVE Technology Group, Inc. | — | Telecommunications | Series B | $17.5M | $336.8M | 2015 |
| Encentrio Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $400K | $4.1M | 2023 |
Sung Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sung Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| George Scangos | 1 | 4 |
| Thomas Hecht | 1 | 2 |
| Jin Kang | 1 | 2 |
| Yee-Ping ` Chu | 1 | 2 |
| Kyutaek Cho | 1 | 1 |
| Johanna Friedl-Naderer | 1 | 1 |
| Natascha Schill | 1 | 1 |
| Vanina De Verneuil | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.